Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters

Contraception

Volumn 54, Issue 2, 1996, Pages 79-86

  Croxatto, Horacio B ^a,c   Massai, M R ^a   Salvatierra, A M ^a   Fuentealba, B ^a   Croxatto, H D ^a   Lahteenmaki P ^b  

^a Chilean Institute for Reproductive Medicine   (Chile)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Instituto Chileno de Medicina Reproductiva   (Chile)

Author keywords

antiprogestin; bleeding pattern; endometrium; mifepristone; ovulation inhibition; progestin; RU486

Indexed keywords

ANTIGESTAGEN; ESTRADIOL; GESTAGEN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; PROGESTERONE;

ADULT; ANOVULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENDOMETRIUM; FEMALE; HORMONAL CONTRACEPTION; HUMAN; HUMAN EXPERIMENT; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; NORMAL HUMAN; OVARY FOLLICLE DEVELOPMENT; OVULATION INHIBITION; SPOTTING;

EID: 0030222227     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(96)00138-2     Document Type: Article

References (14)

1. 1. Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SSC. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486. J Clin Endocrinol Metab 1987;57:797-802.
2. 2. Luukkainen T, Heikinheimo O, Haukkamaa M, Lähteenmäki P. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU486. Fertil Steril 1988; 49:961-8.
3. 3. Ledger WL, Sweeting VM, Hillier H, Baird DT. Inhibition of ovulation by low-dose mifepristone (RU486). Human Reprod 1992;7:945-50.
4. 4. Croxatto HB, Salvatierra AM, Croxatto HD, Fuentealba B. Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle. Human Reprod 1993;8:201-7.
5. 5. Kekkonen R, Alfthan H, Haukkamaa M, Heikinheimo O, Luukkainen T, Lähteenmäki P. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin. Fertil Steril 1990;53:747-50.
6. 6. Kekkonen R, Lähteenmäki P, Luukkainen T, Tuominen J. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception. Fertil Steril 1993;60:610-5.
7. 7. Kekkonen R, Croxatto HB, Lähteenmäki P et al. Effects of intermittent antiprogestin RU486 combined with cyclic medroxyprogesterone acetate on folliculogenesis and ovulation. Human Reprod 1995;10:287-92.
8. 8. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-5.
9. 9. Maqueo M. Vascular and perivascular changes in the endometrium of women using steroidal contraceptives. In: Diczfalusy E, Fraser, Webb FTG, eds. Endometrial Bleeding and Steroidal Contraception. Bath:Pitman Press, 1980:138-52.
10. 10. Heikinheimo O, Tevilin M, Shoupe D, Croxatto H, Lähteenmäki P. Quantitation of RU 486 in human plasma by HPLC and RIA after column chromatography. Contraception 1986;34:613-24.
11. 11. Croxatto HB, Salvatierra AM, Fuentealba B. Follicle stimulating hormone-granulosa cell axis involvement in the antifolliculotropic effect of low dose mifepristone (RU486). Human Reprod 1995;10:101-5.
12. 12. Spitz IM, Croxatto HB, Salvatierra AM, Heikinheimo O. Response to intermittent RU486 in women. Fertil Steril 1993;59:971-5.
13. 13. Croxatto HB, Salvatierra AM, Fuentealba B, Zurth C, Beier S. Effect of the antiprogestin onapristone on follicular growth in women. Human Reprod 1994;9: 1442-7.
14. 14. van Uem JFHM, Hsiu JG, Chillik CF et al. Contraceptive potential of RU486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen-induced endometrial proliferation. Contraception 1989; 40:171-84.